Michael Mollerus
Lawyers
Filters
Smith+Nephew acquisition of CartiHeal
We are advising Smith+Nephew on the acquisition
Polaris $500 million debut senior notes offering
We advised Polaris on its inaugural investment-grade notes offering
Service Properties Trust $1 billion senior secured notes offering
We advised SVC on its high-yield secured notes offering
Amneal Pharmaceuticals $2.35 billion term loan
We advised Amneal Pharmaceuticals on a new term loan
Venture Global LNG $1 billion senior secured notes offering
We advised Venture Global on its high-yield debt offering
Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
We are advising Roche on the acquisition
Coty €500 million senior secured notes offering
The 5.75% senior secured notes are due 2028
JBS USA $2.5 billion senior notes offerings
The investment-grade notes are due 2034 and 2053
Arm $4.87 billion IPO
The deal is the largest U.S. IPO since November 2021
MSCI $697 million acquisition of Burgiss Group
We are advising MSCI on the acquisition